Gatunan, Richie .
HRN: 16-07-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2023
05/04/2023
IV
500mg
Q8h
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes